Biofil Chemicals & Pharmaceuticals (BOM:524396) EV-to-Revenue : 2.87 (As of May. 15, 2024)

Biofil Chemicals & Pharmaceuticals EV-to-Revenue Chart

Biofil Chemicals & Pharmaceuticals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-Revenue		Get a 7-Day Free Trial					0.53	0.44	2.99	4.22	2.26

Biofil Chemicals & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															4.98	2.26	3.58	2.28	2.29

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofil Chemicals & Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's EV-to-Revenue falls into.

Biofil Chemicals & Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biofil Chemicals & Pharmaceuticals's EV-to-Revenue for today is calculated as:

Biofil Chemicals & Pharmaceuticals's current Enterprise Value is ₹1,101.9 Mil.
Biofil Chemicals & Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹384.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals  (BOM:524396) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biofil Chemicals & Pharmaceuticals's PS Ratiofor today is calculated as:

Biofil Chemicals & Pharmaceuticals's share price for today is ₹67.40.
Biofil Chemicals & Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹24.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description